

























Chartered Accountant ( 公認会計士) (공인 회계사 )(CONTABILISTAS) (CONTADORES PÚBLICOS) (ДИПЛОМИРОВАННЫЕ БУХГАЛТЕРЫ СЧЕТОВОДИТЕЛИ) (会计师事务所) (COMPTABLES CHARTERES) (WIRTSCHAFTSPRÜFER) (сметководители) (MUHASEBE MÜTEAHHİTLİĞİ) (محاسبون قانونيون) (CHARTERED AKUNTAN)(Geoktrooieerde Rekenmeesters)(registeraccountants)(RAGIONIERI REGISTRATI)חשבונות רואי חשבון) (This blog is non-commercial and is used here to put important news only for the educational purpose of Students doing CA and CS.



























Reliance Power share price today opened upside and went on to hit intraday high of ₹17.50 apiece levels, logging more than 6 per cent rise in last two sessions. On Thursday, Reliance Power shares had closed at ₹16.75 apiece levels, this means this Anil Ambani-owned company's stock has risen more than 4 per cent in early morning deals on Friday trade session
As per the information available on BSE block deals, BlackRock's ETF, iShares MSCI India Small Cap ETF has bought 11,89,220 Reliance Power shares paying ₹16.40 apiece. This means, core ETF of BlackRock has invested ₹1,95,03,208 or ₹1.95 crore in this Anil Dhirubhai Ambani Group or ADAG stock. Likewise, BlackRock's iShares Core MSCI Emerging Markets ETF bought 72,03,127 Reliance Power shares paying ₹16.40 apiece. This means this core ETF of BlackRock has invested ₹11,81,31,282.80 or around ₹11.81 crore in this ADAG stock.
As per Reliance Power shareholding pattern for April to June 2022 quarter, FPIs hold 26,47,64,114 shares or 7.79 per cent stake in the company. Out of these 7.79 per cent stake, FPI's like Vanguard Emerging Markets Stock Index Fund hold 3,56,72,087 shares or 1.05 per cent stake in the company whereas Vanguard Total International Stock Index Fund holds 3,40,63,528 Reliance Power shares, which is 1 per cent of total paid up capital of the company.
Among DIIs, Life Insurance Corporation of India or LIC of India holds 10,27,58,930 Reliance Power shares, which is 3.02 per cent of total paid up capital of the company.

An eight-month-old baby girl along with her Indian-origin parents and uncle living in the US, who were abducted at gunpoint earlier this week in California
The family, according to authorities were taken by a convicted robber who tried to kill himself a day after the kidnappings.
The Sheriff described it as a "horribly senseless" act and said that the police did not know the "motivation yet."
"We have a whole family wiped out and for what? We don't know yet," he said.
36-year-old Jasdeep Singh, 27-year-old Jasleen Kaur, their eight-month-old child Aroohi Dheri, along with 39-year-old Amandeep Singh were abducted, police said.
The news of the missing family was reported on Monday after local authorities found the missing victim's truck on fire in a rural area outside the Merced Country.
A surveillance video that was released by the Twitter handle of the Merced County Sheriff's office showed the suspect leading Jasdeep Singh who was carrying baby Aroohi in her arms into a truck and driving away.
California fire officials discovered Amandeep Singh's truck ablaze in a rural area outside Merced.
"..received information that one of the victim's ATM cards was used at an ATM located at a bank in the City of Atwater. Investigators obtained the surveillance photo of a subject making a bank transaction where the person is similar in appearance to the surveillance photo from the original kidnapping scene," the Merced County Sheriff's Office said in a statement.
Authorities have identified the suspect in the kidnapping as one 48-year-old Jesus Manuel Salgado and have taken him into custody. Prior to law enforcement involvement, Salgado attempted to take his own life and is currently receiving medical attention and in critical condition, the Sheriff's office statement said.
On Monday, Merced County Sheriff informed that there is evidence leading investigators to believe that the suspected kidnapper attempted to destroy evidence.

Haryana based, Maiden pharmaceuticals company was red flagged by the World Health Organisation due to its potential involvement in the deaths of children in GambiaIndian drug manufacturer, Maiden pharmaceuticals garnered worldwide attention after the World Health Organisation (WHO) issued an alert on its medical cough syrups for their potential links with deaths of around 66 children in Gambia, Africa.
The company has a large international presence, and WHO's call to regulators to remove its products from the market can cause major disruptions in its supply chain to multiple countries in Africa, Asia, Eastern Europe, the Middle East and Russia.
WHO Director General Tedros Adhanom Ghebreyesus, told in a press briefing on Wednesday that the World Health Organisation placed a medical product alert on Maiden pharma's cough syrups for its connections with the kidney injuries and around 66 deaths of children in Gamibia, Africa.
The company was established in 1990 and within three decades it has attained a sound production line and established itself in the field of research and development.
The company has a large international manufacturing presence and is known for its reasonable wide range of medicines. Know more about the Indian company that came under WHO’s scanner for its alleged discrepancies in the supply of toxic cough syrup.
With its two Haryana based manufacturing plants, Maiden pharmaceuticals is able to manufacture a large range of medicine products in massive amounts. According to the company website, Maiden Pharmaceuticals is able to produce 100 million tablets and 60 million capsules in a month. Talking about injections, the company produces around 6 million liquid injections and the same amount of dry powder injections. In addition to this, the company manufactures 10 million of oral liquids and 5 million of ointments along with 5 million of eye drops on a monthly basis.
From life saving drugs to anti-allergics and antibiotics, the company produces a vast variety of medicine products in every category.
Cough and Cold- Maiden pharmaceuticals produces around 13 to 15 products under this category. The company produces medicines in the form of capsules, tablets, and syrups for adults as well as for children.
Antibiotics- The company produces around 40-50 products under this category.
Anti-Allergics and Antifungal- From tablets to capsules, to ointments, Maiden pharmaceutical manufacturers around 10-15 medicines of this category.
Anti Malarials and PainKillers- Such kinds of medicines have huge demand not only in India but also in tropical countries like South Africa, Namibia, etc, where malaria is a widespread disease. The pharmaceutical company produces around 10 different products under these two categories. Along with this, it also produces Effective Dysfunction medicines as well.
Cardiac Care and Diabetes- With the rising patients of diabetes and increasing cases of cardiac arrests and heart patients the company holds a significant share in the diabetes drug market of India. It manufactures around 18 to 20 cardiac medicines and 5 diabetes medicines.
Others- Besides the above mentioned categories, Maiden pharma manufactures medicines in several other categories like anticonvulsants, derma care, critical care, proton pump inhibitors, corticosteroids, etc.
South Africa is not the only international destination of Maiden Pharmaceuticals’s medicine products. Following is the full list of countries, where the company exports its medicine products.
Company exports its medicines to Libya, Liberia, Burkina Faso, Cambodia, Sudan, Nigeria, Botswana, Sierra Leonean, Dominician, Republic. It also exports products to middle east countries like Iran, Iraq, Turkey, Afghanistan, Turkey, UAE, etc. In Asia, its has exports to Myanmar,Bhutan, Phillipenes, etc. Apart from this, the company also exports to Venezula, Chile, Costa Rica, Ivory Coast,etc.